Abstract

Diagnosing acute heart failure (AHF) in the undifferentiated dyspneic emergency department (ED) patient can be challenging, even with natriuretic peptide binary testing. Structured on a Bayesian approach, we had retrospectively derived and validated a promising mathematical diagnostic model (SoB-HF) for potential AHF cases based simply on initial clinical impression, patient age and absolute NT-proBNP value. We sought to prospectively compare the diagnostic accuracy of SoB-HF with that of emergency physician (EP) pretest probability for AHF, NT-proBNP binary value and final EP diagnosis (EPDx). Undifferentiated dyspneic ED patients with an EP assessed initial indeterminate (21-79%) pretest probability for AHF were enrolled across 4 international sites. At time of ED disposition, the EP recorded EPDx as “AHF” or “no AHF”. Receiver-operator characteristic (ROC) curves were constructed and area under the curve (AUC) calculated to illustrate both pretest AHF and SoB-HF posttest value agreement with gold standard adjudicated diagnosis by two blinded cardiology experts (AdjDx) with post index visit 60 day records For model agreement, optimal cut-points using sensitivity, specificity and likelihood ratios (LR) were calculated. If the SoB-HF model showed superior performance, then an App would be created to facilitate its use. One hundred ninety seven patients were enrolled (43% male, mean age 64 years, 53% with a history AHF, 49% with a history COPD), EP pretest AHF had a ROC AUC of 0.76 vs. 0.93 for SoB-HF (p = 0.000001). Adj Dx was 40% prevalence AHF. EPDx accuracy was 75%. NT-proBNP testing with standard cut-points had 88% (95% CI 79, 94) sensitivity, 78% (95% CI 70, 84) specificity. SoB-HF posttest optimal single cutpoint of 0.515 had 90% (95% CI 82, 96) sensitivity, 88% (95% CI 82, 93) specificity. SoB-HF posttest values > 0.65 had a +LR>10 and posttest values < 0.47 had a -LR of <0.1, together redirecting 84% of uncertain cases with 92% accuracy. An App was created to calculate the SoB-HF probability value and its corresponding LR. This simple clinical decision tool demonstrates superior diagnostic accuracy in a prospective cohort of dyspneic ED patients with an indeterminate pretest probability for AHF. With clinical implementation, further studies of its sensitivity and impact analyses are warranted.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call